These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10221512)
1. High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow. Santini G; De Souza C; Congiu AM; Nati S; Marino G; Soracco M; Sertoli MR; Rubagotti A; Spriano M; Vassallo F; Rossi E; Vimercati R; Piaggio G; Figari O; Benvenuto F; Abate M; Truini M; Ravetti JL; Ribizzi I; Damasio E Leuk Lymphoma; 1999 Apr; 33(3-4):321-30. PubMed ID: 10221512 [TBL] [Abstract][Full Text] [Related]
2. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group. Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723 [TBL] [Abstract][Full Text] [Related]
3. High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma. Baldissera RC; Aranha JF; Oliveira GB; Vigorito AC; Eid KA; Miranda EC; De Souza CA Braz J Med Biol Res; 2002 Jan; 35(1):49-57. PubMed ID: 11743614 [TBL] [Abstract][Full Text] [Related]
4. Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement. Santini G; Congiu AM; Nati S; Pierluigi D; Spriano M; Chisesi T; Rossi E; Vimercati R; Sertoli MR; Figari O; Gobbi M; Piaggio G; Vassallo F; Benvenuto F; Soracco M; Miglino M; Bruni R; Ravetti JL; Truini M Leukemia; 1996 Jun; 10 Suppl 2():s88-91. PubMed ID: 8649061 [TBL] [Abstract][Full Text] [Related]
5. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159 [TBL] [Abstract][Full Text] [Related]
6. Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement. Santini G; Congiu AM; Nati S; Canepa L; Spriano M; Chisesi T; Rossi E; Vimercati R; Sertoli MR; Figari O; Gobbi M; Piaggio G; Vassallo F; Benvenuto F; Soracco M; Miglino M; Ravetti JL; Truini M Leuk Lymphoma; 1997 Dec; 26 Suppl 1():83-8. PubMed ID: 9570684 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation. Miglino M; Santini G; Grasso R; Pietrasanta D; Clavio M; Pierri I; Canepa L; Nati S; Ballerini F; Varaldo R; Palmisano G; Gobbi M Haematologica; 2001 Jul; 86(7):706-14. PubMed ID: 11454525 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis. Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930 [TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
10. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma. Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcome. Tarella C; Castellino C; Cherasco C; Bondesan P; Giaretta F; Corradini P; Caracciolo D; Gavarotti P; Pileri A Br J Haematol; 1997 Oct; 99(1):41-6. PubMed ID: 9359500 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma. Tarumi T; Sawada K; Koizumi K; Takano H; Fukada Y; Nishio M; Fujie T; Ohnishi K; Kohno M; Sato N; Sekiguchi S; Koike T Leuk Lymphoma; 1999 Jul; 34(3-4):361-71. PubMed ID: 10439373 [TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma. Ballestrero A; Clavio M; Ferrando F; Gonella R; Garuti A; Sessarego M; Ghio R; Gobbi M; Patrone F Int J Oncol; 2000 Nov; 17(5):1007-13. PubMed ID: 11029505 [TBL] [Abstract][Full Text] [Related]
14. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091 [TBL] [Abstract][Full Text] [Related]
15. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928 [TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
17. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200 [TBL] [Abstract][Full Text] [Related]
18. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence. Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087 [TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma. Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778 [TBL] [Abstract][Full Text] [Related]
20. Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma. Kriegsmann K; Rieger M; Schwarzbich MA; Sitter S; Kriegsmann M; Bruckner T; Hensel M; Ho AD; Witzens-Harig M; Wuchter P Eur J Haematol; 2018 Jul; 101(1):12-20. PubMed ID: 29575332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]